cp wire

CP Wire Articles

Merck to Acquire Animal Tracking and Monitoring Company

Merck [NYSE:MRK] and privately held Antelliq Group announced on 12/14/18 that the companies have signed a definitive agreement under which Merck will acquire Antelliq from funds advised by BC... read more

Fri, 12/14/18 - 10:40 am
admin
Two Life Science Accelerators Announce New Lab Space

Two programs (one in the US and one in the UK) offering life science companies lab space and access to capital and advisors made announcements about lab space for seed and early stage
... read more

Fri, 12/14/18 - 10:03 am
admin
Pfizer Initiates Ph III Trials for Invasive Pneumococcal Disease and Pneumonia Vaccine
  • The vaccine received Breakthrough Therapy designation in September, 2018
  • It received Fast Track designation in October, 2017


Pfizer Inc. (NYSE:PFE) announced today... read more

Fri, 12/14/18 - 09:10 am
admin
Tremfya Demonstrates Superiority Over Cosentyx in Ph III Data in Moderate to Severe Plaque Psoriasis

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from the ECLIPSE study demonstrating that Tremfya (guselkumab) was superior to Cosentyx (secukinumab)* in... read more

Wed, 12/12/18 - 10:46 am
admin
Bristol-Myers Squibb and Vedanta Biosciences to Evaluate Opdivo and VE800 in Patients with Advanced or Metastatic Cancers
  • VE800, is based on work showing in preclinical models that certain gut-dwelling bacterial strains potentiate cytotoxic CD8+ T cells and enhance infiltration into tumors
  • Bristol-Myers... read more
Mon, 12/10/18 - 10:57 pm
admin
Microbiome Report for Week Ending 12/1/18


Evelo Biosciences Announces First Dosing in Phase... read more

Sat, 12/8/18 - 01:59 pm
admin
Biological Dynamics Selected as Winner of CONNECT’s 2018 Most Innovative New Product Award

Biological Dynamics announced on 12/7/18 that its OmniVerita system has been selected as the winner of CONNECT’s Most Innovative New Product Award in the Life Science Products, Clinical Stage... read more

Fri, 12/7/18 - 10:36 am
admin
Kallyope Receives $21 Million in Series B Financing to Target the Gut-Brain Axis


Kallyope Inc., a leading biotechnology company focused on identifying therapeutic opportunities involving the gut-brain axis, today announced a $21 million expansion of its previously... read more

Wed, 12/5/18 - 02:44 pm
admin
Clovis Oncology Prevails in European Patent Proceedings Related to Rubraca
  • Ruling will confirm European regulatory exclusivity for Rubraca until at least 2028
  • Clovis also recently received a patent for using Rubraca in high doses to treat cancer in the US... read more
Tue, 12/4/18 - 09:13 am
admin
Proteintech Partners With AI Driven BenchSci to Boost Researchers’ Antibody Data Searches


Proteintech, the benchmark in antibodies since 2001, and BenchSci, a life science machine learning startup backed by Google’s AI fund, have announced a new partnership to accelerate science by... read more

Mon, 12/3/18 - 10:33 am
admin
Aetna and Ascension Join Group in Blockchain-Driven Effort to Make Health Care Provider Data Accessible to Consumers

Aetna, a CVS Health business, and Ascension have joined the pilot project applying blockchain technology to improve data quality and reduce administrative costs associated with changes to health... read more

Mon, 12/3/18 - 10:10 am
admin
ResMed to Acquire Innovative Propeller Health for $225 Million

ResMed (NYSE: RMD) (ASX: RMD), a leader in cloud-connected medical devices and out-of-hospital software-as-a-service (SaaS) business solutions, announced on 12/3/18 that it has entered a... read more

Mon, 12/3/18 - 09:55 am
admin
Microbiome Report for Week Ending 11/24/18

Infant Bacterial Therapeutics Modifies Ph III Protocol After Meeting with FDA... read more

Thu, 11/29/18 - 09:50 am
admin
European Commission Approves Kalydeco to Treat Cystic Fibrosis


Vertex Pharmaceuticals (Europe) Limited announced on 11/29/18 that the European Commission has granted approval of the label extension for Kalydeco (ivacaftor) to include the treatment of... read more

Thu, 11/29/18 - 09:31 am
admin
Ireland and Industry Leaders Announce $400 Million Program to Create Genomic Research Hub
  • The program brings together many industry heavyweights including: WuXi NextCODE, ARCH Venture Partners, Polaris Partners and Sequoia Capital
  • The Ireland Strategic Investment Fund is... read more
Wed, 11/28/18 - 09:31 am
admin
Biotech Showcase Conference Reveals Six Therapeutic Areas Receiving the Most Investment Attention in 2019



Biotech Showcase™, one of the largest biotech investor conferences in the world, announced on 11/27/18 this year’s conference agenda which highlights six therapeutic areas that are... read more

Tue, 11/27/18 - 10:37 am
admin
Rheostat Therapeutics Raises $23 Million from Heavyweight Pharma Companies in Series A Round
  • Merck, Abbvie and Amgen VC groups participated
  • Rheostat is focused on developing novel treatments for neurodegeneration, cognition and rare diseases


Rheostat... read more

Mon, 11/26/18 - 10:02 am
admin
Rocket Pharmaceuticals Releases Preclinical Data for First Investigational Gene Therapy Program for Rare Heart Disorder
  • Danon disease has an estimated prevalence of about 15,000-30,000 patients in the U.S. and E.U.
  • ... read more
Mon, 11/26/18 - 09:46 am
admin
Cyclica Partners with Bayer to Advance its AI-Augmented Network of Cloud-Based Technologies

Cyclica announced on 11/26/18 a collaboration with Bayer to advance drug discovery programs by gaining insights into the polypharmacological profiles of small... read more

Mon, 11/26/18 - 09:34 am
admin
Infant Bacterial Therapeutics Delays Ph III Start Date After Meeting with FDA
  • Trial expected to start in 1H2019
  • Improved protocol may allow for additional claims

Following its meeting with the US Food and Drug Administration (FDA) in Washington DC... read more

Sat, 11/24/18 - 11:06 am
admin

Pages



current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.